Abstract
The Research Investments in Global Health (RESIN) study is an analysis of global investments in health research, and is based at the University of Southampton.
We analyses funding decisions and look at knowledge strengths and research gaps. For example, see the 2020 paper covering $105 billion of public and charitable research investment around global infectious disease research. https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(20)30357-0/fulltext
Ongoing work includes global research funding of oncology research and initial look at the impact of the pandemic on cancer funding. We are also bringing together 'all health research globally' to perform an analysis of the spend on each key area of health, over time, and to ascertain where strengths and gaps are going forward. Our data is used and absorbed by the WHO R&D Observatory, and also funding bodies including Wellcome, Gates Foundation and the NIHR.
Aim
Aim
- to analyse funding decisions in health research at individual award level
Objectives
- look at knowledge strengths and research gaps
- to describe funding over time
- to describe funding by type of science along the research pipeline (e.g. pre-clinical / trials / public health research)
- to compare funding with other metrics such as national and global burden of disease
Intended Impact of the Study
- Information provided about knowledge strengths and gaps in the research landscape. This information has been useful to funders, stakeholders such as the WHO, and researchers.
Project Lead
Project Collaborators
Professor Rifat Atun, Harvard University
Dr Rebecca Brown, Clinical Informatics Research Unit, University of Southampton
Keywords
URL
Research Area(s)
Study Design(s)
Data Collection Method(s)
Participant(s)
Other Participants: data comes from funders and funding databases
Status
Expected completion date: